Health Monthly Martinique: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monthly Martinique.

Press releases published on May 5, 2026

May 5, 2026

ISOThrive Reports Highly Statistically Significant Phase 2 Data for MHS-1031 in NERD Patients at DDW 2026

Indeterminate GlobeNewswire

May 5, 2026

Biomea Fusion Announces Poster Presentations of Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions

Indeterminate GlobeNewswire

May 5, 2026

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 5, 2026

EPIK Biosciences Launches to Pioneer Ketamine-Powered Psychedelic Therapies to Transform Treatment of Mental Health, Pain, and Addiction

Indeterminate GlobeNewswire

May 5, 2026

Aura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire

May 5, 2026

Theriva™ Biologics Reports First Quarter 2026 Operational Highlights and Financial Results

Indeterminate GlobeNewswire

May 5, 2026

STERIS Announces Dividend of $0.63 per share

Indeterminate GlobeNewswire

May 5, 2026

FDA Expands Market Access, Authorizes New ENDS Products

Indeterminate GlobeNewswire

May 5, 2026

Pacira BioSciences Mails Letter to Stockholders

Indeterminate GlobeNewswire

May 5, 2026

Longeveron to Report 2026 First Quarter Financial Results and Host Conference Call on May 13, 2026

Indeterminate GlobeNewswire

May 5, 2026

Sienna Reports First Quarter 2026 Financial Results and Continues Platform Expansion

Indeterminate GlobeNewswire

May 5, 2026

Cytokinetics Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire

May 5, 2026

Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference

Indeterminate GlobeNewswire

May 5, 2026

Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

May 5, 2026

Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

May 5, 2026

InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2026

Indeterminate GlobeNewswire

May 5, 2026

Supernus Announces First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 5, 2026

LeMaitre Q1 2026 Financial Results

Indeterminate GlobeNewswire

May 5, 2026

Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (SID) Annual Meeting 

Indeterminate GlobeNewswire

May 5, 2026

OnKure Therapeutics Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire